Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: MicroRNA-33-5p inhibits cholesterol efflux in vascular endothelial cells by regulating citrate synthase and ATP-binding cassette transporter A1

Fig. 1

Effect of ox-LDL on VECs. A The levels of HMGCR, ABCA1, CS, and miR-33-5p mRNA expression in response to ox-LDL treatment. B, C the expression of HMGCR, ABCA1, and CS proteins in response to ox-LDL treatment. D, E the percentages of apoptotic VECs after ox-LDL treatment. Ox-LDL, oxidized low-density lipoprotein. Ox-LDL-low: 50 μg/mL; ox-LDL-moderate: 100 μg/mL; ox-LDL-high: 200 μg/mL. **p < 0.01 vs. control by one-way ANOVA followed by the Tukey’s post hoc test. &&p < 0.01 vs. moderate by one-way ANOVA followed by the Tukey’s post hoc test.The above experiments were repeated three times and the mean value was obtained. The original bands of WB are presented in Additional file 1: [1A]

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us